POLYPID
PolyPid is a development stage company that has developed a platform technology for the healthcare industry that enables a controlled and prolonged release of any active pharmaceutical ingredients (API). PolyPid’s technology combines polymers and lipids, enabling small-and-large API entrapment in degradation and hydration protected environments, regardless of their chemical or physical characteristics. PolyPid allows the release of the API from the reservoir at pre-determined rates of up to several months, with a constant release rate (zero-order kinetics). The flexibility of this innovative technology enables local administration of compounds across numerous therapeutic classes for several applications.
POLYPID
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2008-01-01
Address:
Petah Tiqva, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.polypid.com
Total Employee:
51+
Status:
Active
Contact:
972 7 4719 5700
Total Funding:
139.8 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Google Font API WordPress Content Delivery Network Font Awesome IPv6 Sitelinks Search Box
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Zai Lab
Zai Lab brings transformative medicines for cancer, autoimmune, and infectious diseases to patients in China and around the world.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Rosalind Capital Partners
Rosalind Capital Partners investment in Post-IPO Equity - PolyPid
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - PolyPid
Kreos Capital
Kreos Capital investment in Post-IPO Debt - PolyPid
Apple Core Holdings
Apple Core Holdings investment in Series E - PolyPid
Shavit Capital
Shavit Capital investment in Series D - PolyPid
Chaim Hurvitz
Chaim Hurvitz investment in Series D - PolyPid
Aurum Ventures
Aurum Ventures investment in Series D - PolyPid
Financiere Saint James
Financiere Saint James investment in Series C - PolyPid
GUIBOR
GUIBOR investment in Series C - PolyPid
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-03 | PolyPid Announces Planned CEO Transition Current EVP & CFO, Dikla Czaczkes Akselbrad, Appointed CEO, Effective July 2022 |
Official Site Inspections
http://www.polypid.com Semrush global rank: 4.36 M Semrush visits lastest month: 2.26 K
- Host name: 0.69.165.34.bc.googleusercontent.com
- IP address: 34.165.69.0
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PolyPid"
Overview | PolyPid
PolyPid Ltd. (Headquarters) 18 Hasivim Street, P.O Box 7126 Petach Tikva, Israel 4917002. Phone: +972-74-719-5700. PolyPid Inc. 372 Franklin Ave. P.O. Box 558See details»
PolyPid - Crunchbase Company Profile & Funding
PolyPid is a development stage company that has developed a platform technology for the healthcare industry that enables a controlled and prolonged release of any active …See details»
Polypid Org Chart + Executive Team - The Official Board
Organizational Chart of Polypid. Polypid Org Chart www.polypid.com. has 17 executives +972 747 195 700; Add an executive. Latest news on Polypid (PYPD) Anything missing? We search …See details»
PolyPid Company Profile | Management and Employees List
PolyPid Profile and History. PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged …See details»
PolyPid - Israeli Startup | Startup Nation Finder
Dec 24, 2024 PolyPid is a late-stage biopharmaceutical company focused on improving surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid’s proprietary PLEX (Polymer-Lipid …See details»
PolyPid - The Org
PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).See details»
PolyPid - Contacts, Employees, Board Members, Advisors & Alumni
Organization. PolyPid . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. PolyPid has 4 current employee profiles, …See details»
Overview - PolyPid
We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid …See details»
PolyPid Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API). Its technology combines …See details»
Board of Directors - PolyPid
Ms. Dikla Czaczkes Akselbrad serves as the Chief Executive Officer of PolyPid after serving as the company’s EVP and CFO since 2017, leading the company’s initial public offering on the …See details»
PolyPid Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore PolyPid Ltd. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 84 news, and 8 literature, Disease Domain:Neoplasms, Nervous ...See details»
PolyPid Provides Corporate Update and Reports First Quarter 2025 ...
Mar 31, 2025 PolyPid is not responsible for the contents of third-party websites. Contacts: PolyPid Ltd. Ori Warshavsky COO – US 908-858-5995 [email protected] . Investors: Brian …See details»
PolyPid Company Profile, Investors, & Funding | Lucidity Insights
Jan 1, 2010 PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API). Total Fundraised $5B. PE Round. Late …See details»
PolyPid Announces Positive Recommendation by DSMB to …
Dec 24, 2024 PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release …See details»
PolyPid: Innovating Localized Drug Delivery Solutions for Precision ...
Dec 4, 2024 PolyPid’s goals in the coming years center around advancing our PLEX platform and expanding its pipeline of therapeutic solutions. Our immediate priority is the successful …See details»
PLEX PLATFORM PIPELINE - PolyPid
PolyPid Ltd. (Headquarters) 18 Hasivim Street, P.O Box 7126 Petach Tikva, Israel 4917002. Phone: +972-74-719-5700. PolyPid Inc. 372 Franklin Ave. P.O. Box 558 Nutley NJ 07110 …See details»
PolyPid: Creating 'revolutionary' biotech | Health Tech World
Aug 10, 2022 Israeli clinical-stage bio-pharmaceutical company PolyPid has created an exciting new technology that enables the controlled and continuous delivery of drugs to surgical sites.See details»
PolyPid. Information about the issuer. . News and credit ratings ...
You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFsSee details»
Careers - PolyPid
For employment consideration, please send your resume and cover letter to [email protected]. Career Opportunities. PolyPid Ltd. (Headquarters) 18 Hasivim Street, P.O Box 7126 Petach …See details»
Working At PolyPid: Company Overview and Culture - Zippia
Zippia gives an in-depth look into the details of PolyPid, including salaries, political affiliations, employee data, and more, in order to inform job seekers about PolyPid. The employee data is …See details»